Fever of unknown origin: Prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 5, 2004, Pages 622-626

  Kjaer, Andreas ^a   Lebech, Anne Mette ^a   Eigtved, Annika ^a   Højgaard, Liselotte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

FDG PET; Fever of unknown origin; Granulocyte scintigraphy; Leucocyte scintigraphy; Nuclear medicine

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GRANULOCYTE IN 111; INDIUM 111; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GRANULOCYTE; GRANULOCYTE SCINTIGRAPHY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LEUKOCYTE; MALE; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; SCINTIGRAPHY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 2442473863     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1425-5     Document Type: Article

References (18)

1. Amow PM, Flaherty JP. Fever of unknown origin. Lancet 1997; 350:575-580.
2. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003; 163:545-551.
3. Mourad O, Palda V, Detsky AS. Review: fair evidence supports several tests in investigating fever of unknown origin. Evidence Based Medicine 2003; 8:156.
4. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001; 1:326-333.
5. Corstens FH, van der Meer JW. Nuclear medicine's role in infection and inflammation. Lancet 1999; 354:765-770.
6. Peters AM. Nuclear medicine imaging in fever of unknown origin. Q J Nucl Med 1999; 43:61-73.
7. 111In-granulocyte scintigraphy in patients with fever of unknown origin. J Nucl Med 2002; 43:140-144.
8. 18F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191-196.
9. 18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 27:1617-1625.
10. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001; 22:779-783.
11. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994; 35:1398-1406.
12. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1981.
13. de Kleijn EM, van der Meer JW. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth J Med 1995; 47:54-60.
14. de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) 1997; 76:392-400.
15. Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992; 152:51-55.
16. Davies SG, Garvie NW. The role of indium-labelled leukocyte imaging in pyrexia of unknown origin. Br J Radiol 1990; 63:850-854.
17. Schmidt KG, Rasmussen JW, Sorensen PG, Wedebye IM. Indium-111-granulocyte scintigraphy in the evaluation of patients with fever of undetermined origin. Scand J Infect Dis 1987; 19:339-345.
18. Syrjala MT, Valtonen V, Liewendahl K, Myllyla G. Diagnostic significance of indium-111 granulocyte scintigraphy in febrile patients. J Nucl Med 1987; 28:155-160.